Profil Tekanan Darah pada Pasien Anemia yang Mendapat Terapi Esa di Bagian Penyakit Dalam RSUP H. Adam Malik Medan
DAFTAR PUSTAKA
Price, S.A. Patofisiologi, Konsep Klinis Proses-Proses Penyakit. Edisi ke-6.
Jakarta: EGC, 2005. Hal. 912-918. Vol 2
Permadi B.H. Cara Kerja Mesin Hemodialisis. Makasar: Jurusan Elektro
Fakultas Teknik Universitas Hasanuddin. 2011. Diunduh dari URL:
http://www.scribd.com/doc/86881359/Cara-Kerja-Mesin-Hemodialisis-2
Zadeh, K.K, Aronoff, G.R. Hemoglobin Variability in Anemia of Chronic Kidney
Disease. J Am Soc Nephrol ( serial online) 2009 (diakses pada tanggal 12
mei
2012).
Diunduh
dari
URL:
http://jasn.asnjournals.org/content/20/3/479.full.pdf
I. K. Gooneratne, A. K. P. Ranaweera, N. P. Liyanarachchi, N. Gunawardane,
and R. D. Lanerolle. Epidemiology of chronic kidney disease in a Sri
Lankan population. Int J Diabetes Dev Ctries. 2008 Apr-Jun; 28(2): 60–
64.
Diunduh
dari
URL:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772012/
Suwitra, Ketut. Gagal Ginjal Kronik, Dalam : Buku Ajar Ilmu Penyakit Dalam FK
UI, Edisi 4, Jilid I, Balai
Catlin DH, Breidbach A, Elliott S, Glaspy J: Comparison of the isoelectric
focusing patterns of darbepoetin alfa, recombinant human erythropoietin,
and endogenous erythropoietin from human urine. Clin Chem 2002,
48:2057-9.
Elliott S, Egrie J, Browne J, Lorenzini T, Busse L, Rogers N, et al: Control of
rHuEPO biological activity: the role of carbohydrate. Exp Hematol 2004,
32:1146-55.
Rush RS, Derby PL, Smith DM, Merry C, Rogers G, Rohde MF, et al:
Microheterogeneity of erythropoietin carbohydrate structure. Anal Chem
1995, 67:1442-52.
Rush RS, Derby PL, Strickland TW, Rohde MF: Peptide mapping and evaluation
of glycopeptide microheterogeneity derived from endoproteinase digestion
of erythropoietin by affinity high-performance capillary electrophoresis.
Anal Chem 1993, 65:1834-42.
Universitas Sumatera Utara
Middleton SA, Barbone FP, Johnson DL, Thurmond RL, You Y, McMahon FJ, et
al: Shared and unique determinants of the erythropoietin (EPO) receptor
are important for binding EPO and EPO mimetic peptide. J Biol Chem
1999, 274:14163-9.
Weidemann A, Johnson RS: Nonrenal regulation of EPO synthesis. Kidney Int
2009,
75:682-8.
Jelkmann W: Erythropoietin after a century of research: younger than
ever. Eur J Haematol 2007, 78:183-205.
Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB: Beyond anemia: the
clinical impact of the physiologic effects of erythropoietin. Semin Dial
2008,
21:447-54.
Bahlmann FH, Fliser D: Erythropoietin and renoprotection. Curr Opin
Nephrol Hypertens 2009, 18:15-20.
Johnson DW, Forman C, Vesey DA: Novel renoprotective actions of
erythropoietin: new uses for an old hormone. Nephrology 2006, 11:30612.
Percy MJ, Lee FS, Percy MJ, Lee FS: Familial erythrocytosis: molecular
links to red blood cell control. Haematologica 2008, 93:963-7.
Universitas Sumatera Utara
Price, S.A. Patofisiologi, Konsep Klinis Proses-Proses Penyakit. Edisi ke-6.
Jakarta: EGC, 2005. Hal. 912-918. Vol 2
Permadi B.H. Cara Kerja Mesin Hemodialisis. Makasar: Jurusan Elektro
Fakultas Teknik Universitas Hasanuddin. 2011. Diunduh dari URL:
http://www.scribd.com/doc/86881359/Cara-Kerja-Mesin-Hemodialisis-2
Zadeh, K.K, Aronoff, G.R. Hemoglobin Variability in Anemia of Chronic Kidney
Disease. J Am Soc Nephrol ( serial online) 2009 (diakses pada tanggal 12
mei
2012).
Diunduh
dari
URL:
http://jasn.asnjournals.org/content/20/3/479.full.pdf
I. K. Gooneratne, A. K. P. Ranaweera, N. P. Liyanarachchi, N. Gunawardane,
and R. D. Lanerolle. Epidemiology of chronic kidney disease in a Sri
Lankan population. Int J Diabetes Dev Ctries. 2008 Apr-Jun; 28(2): 60–
64.
Diunduh
dari
URL:
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2772012/
Suwitra, Ketut. Gagal Ginjal Kronik, Dalam : Buku Ajar Ilmu Penyakit Dalam FK
UI, Edisi 4, Jilid I, Balai
Catlin DH, Breidbach A, Elliott S, Glaspy J: Comparison of the isoelectric
focusing patterns of darbepoetin alfa, recombinant human erythropoietin,
and endogenous erythropoietin from human urine. Clin Chem 2002,
48:2057-9.
Elliott S, Egrie J, Browne J, Lorenzini T, Busse L, Rogers N, et al: Control of
rHuEPO biological activity: the role of carbohydrate. Exp Hematol 2004,
32:1146-55.
Rush RS, Derby PL, Smith DM, Merry C, Rogers G, Rohde MF, et al:
Microheterogeneity of erythropoietin carbohydrate structure. Anal Chem
1995, 67:1442-52.
Rush RS, Derby PL, Strickland TW, Rohde MF: Peptide mapping and evaluation
of glycopeptide microheterogeneity derived from endoproteinase digestion
of erythropoietin by affinity high-performance capillary electrophoresis.
Anal Chem 1993, 65:1834-42.
Universitas Sumatera Utara
Middleton SA, Barbone FP, Johnson DL, Thurmond RL, You Y, McMahon FJ, et
al: Shared and unique determinants of the erythropoietin (EPO) receptor
are important for binding EPO and EPO mimetic peptide. J Biol Chem
1999, 274:14163-9.
Weidemann A, Johnson RS: Nonrenal regulation of EPO synthesis. Kidney Int
2009,
75:682-8.
Jelkmann W: Erythropoietin after a century of research: younger than
ever. Eur J Haematol 2007, 78:183-205.
Diskin CJ, Stokes TJ, Dansby LM, Radcliff L, Carter TB: Beyond anemia: the
clinical impact of the physiologic effects of erythropoietin. Semin Dial
2008,
21:447-54.
Bahlmann FH, Fliser D: Erythropoietin and renoprotection. Curr Opin
Nephrol Hypertens 2009, 18:15-20.
Johnson DW, Forman C, Vesey DA: Novel renoprotective actions of
erythropoietin: new uses for an old hormone. Nephrology 2006, 11:30612.
Percy MJ, Lee FS, Percy MJ, Lee FS: Familial erythrocytosis: molecular
links to red blood cell control. Haematologica 2008, 93:963-7.
Universitas Sumatera Utara